Gene Query: KTN1

Dataset Description Geneva Score
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 79.85
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 53.55
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 51.94
An RNA-centric dissection of host complexes controlling flavivirus infection 49.62
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 49.62
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 45.97
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 45.34
Cleavage Factor Im as a key regulator of 3’ UTR length 45.3
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 44.78
hnRNP C is a key regulator of protein synthesis in mitosis 36.41
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 36.37
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 35.65
FOXD3 is a novel tumor suppressor in lung cancer 34.16
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 33.62
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 32.29
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 32.29
Genes significantly down or Up-regulated upon RNF219 knockdown 31.01
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 30.81
The contribution of Alu exons to the human proteome 30.61
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 29.77
Human cell line and subcutaneous tumor 29.23
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 28.71
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 28.65
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 28.58
hTERT promotes cell adhesion and migration independent of telomerase activity 28.23
Determination of tRNA aminoacylation levels by high throughput sequencing 28.16
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 27.55
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 27.4
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 26.44
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 26.07
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 25.94
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 25.42
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 24.23
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 24.15
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 22.85
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 22.63
Knockdown of ADNP in HCT116 colon cancer cells 22.31
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 21.59
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 21.52
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 21.36
RNA transcriptome analysis during HSV-1 infection 19.76
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 19.4
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 19.3
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 19.28
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 18.64
Exogenous rescue of KLHL9 in SF210 cell line 18.59
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 18.42
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 18.18
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 18.01
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 17.79
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 17.79
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 17.61
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 17.5
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 17.21
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 17.05
Targeting EZH2 in MYCN-amplified Neuroblastoma 16.94
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 16.94
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 16.34
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 16.28
Global expression profiles in cardiac progenitor cells generated by ISX-9 16.26
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 16.26
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 16.15
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 15.83
RNA-Seq of PRMT1 overexpression ECA109 cells 15.77
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 15.6
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 15.5
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 15.35
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 15.3
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 15.23
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 15.22
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 15.16
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 15.16
Recovery and analysis of nascent RNA 15.11
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 15.11
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 14.91
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 14.86
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 14.82
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.68
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.66
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 14.64
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 14.63
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 14.48
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 14.32
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 14.25
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 14.21
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 14.11
3’ Uridylation Expands miRNA Target Repertoire 14.08
Efficient and quantitative high-throughput tRNA sequencing 14.04
Transcriptomic analysis of the HOTAIR-regulated genes 13.96
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 13.59
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 13.54
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 13.54
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.5
Regulation of highly expressed hCINAP on translatome 13.33
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 13.26
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 13.26
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 13.2
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.93
Exploring the RNA landscape of endothelial exosomes 12.55
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 12.55
RNA polymerase in pre-B-ALL cell lines 12.52
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 12.46
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 12.37
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 12.32
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.32
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.32
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 12.18
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 12.13
Comprehensive comparative analysis of 5’ end RNA sequencing methods 12.05
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 11.87
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 11.65
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 11.65
H1609088 Human RNA-Sequencing 11.61
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 11.54
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 11.53
Role of microRNAs in the interaction between Salmonella and the host cell 11.44
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 11.42
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 11.3
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 11.3
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 11.27
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 11.17
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 10.9
RNA-seq of shEZH2 cells 10.79
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 10.55
Differetially expressed genes after hTR overexpression in U2OS cells 10.53
Effect of BMP inhibition or stimulation of primary human keratinocytes 10.53
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 10.53
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 10.52
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 10.5
RNA m5C Methylation in breast cancer using MeRIP-Seq 10.45
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.43
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.38
High-throughput sequencing of PROMPT-enriched samples. 10.28
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 10.23
MYC dependent mRNA translation shapes gene expression and cell biology 10.21
Regulatory network controlling tumor-promoting inflammation in human cancers 10.16
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 10.16
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 10.07
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 10.03
RNA-seq analyses of human prostate cancer cells 9.86
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 9.85
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.84
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.84
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.84
Global analysis of enhancer targets: Mosaic-seq 9.82
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 9.8
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 9.76
Survival of pancreatic cancer cells lacking KRAS function 9.68
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 9.66
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 9.61
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.56
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 9.51
Co-regulation of splicing by Rbfox1 and hnRNP M 9.5
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.5
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 9.47
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 9.26
CROP-Seq in Primary Human T Cells 9.19
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.15
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 9.12
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 9.07
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.92
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 8.81
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.77
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 8.73
Proteomics identifies a marker signature of MAPKi resistance in melanoma 8.72
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.59
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 8.53
Profiling of escape kinetics of viruses subjected to RNAi 8.53
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 8.5
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.48
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.42
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 8.39
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 8.21
RNA-sequencing in irradiated and normal A549 cells. 8.16
K562 polyA RNA-Seq 8.12
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 8.1
Characterization of the Merkel cell carcinoma miRNome 8.07
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.06
Global Mapping of Human RNA-RNA Interactions 8.05
Mitochondrial dsRNA triggers antiviral signalling in humans 8.04
LncRNA-GAS5 negative regulation of YAP-target genes expression 8.01
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.99
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 7.95
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 7.95
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 7.91
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 7.91
METTL3 and WTAP 7.86
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.85
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 7.84
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.84
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.83
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 7.81
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 7.81
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 7.76
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 7.68
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 7.62
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.56
Capturing the Interactome of Newly Transcribed RNA 7.56
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 7.55
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.54
Exploring ILF2 regulatory genes by next-generation sequencing 7.5
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 7.43
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 7.31
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.29
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.29
mRNA expression in human DAOY cells 7.28
Novel Targeting of Transcription and Metabolism in Glioblastoma 7.25
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 7.24
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.2
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.2
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 7.15
Interphase condensins regulate ligand-depedent enhancer activation 7.15
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.13
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 7.13
A transcriptome dataset revealing the molecular features of breast cancer stem cells 7.13
RNA-seq of naive and primed ES cells (NHSM) 7.1
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.06
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.95
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.91
RNA-Seq in neutrophils from Antiphospholipid Syndrome 6.88
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.88
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 6.86
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 6.83
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.79
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.75
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.75
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 6.69
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 6.68
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 6.64
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 6.64
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 6.59
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.55
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.55
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 6.48
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 6.34
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 6.33
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.31
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 6.28
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 6.27
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 6.22
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.14
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.14
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.13
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.13
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 6.11
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 6.11
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 6.11
mRNA recovered upon RNF219 IP. [RNA-IP] 6.08
Identification of renal resident macrophages across species 6.03
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 6.03
Sensing self and nonself circular RNAs 6.02
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.98
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.96
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 5.87
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 5.84
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 5.84
RNA Sequencing of three pairs of gastric cancer 5.82
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 5.78
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.74
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.73
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 5.72
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 5.72
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.69
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 5.67
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.63
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 5.62
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.57
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 5.57
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.33
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.33
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.31
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.31
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.28
BCL11B 5.25
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 5.17
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 5.12
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.08
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 5.05
Gene Expression Profiling of WT and KDM3A Knocked out Cell 5.05
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 4.94
Transcriptomic analysis of human tonsillar TFH subsets 4.87
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.83
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.8
Effect of ILF3 on translation during homeostasis and the antiviral response 4.78
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.72
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 4.65
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.64
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 4.62
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 4.62
RNA-seq of RKO cells with cTAZ KO or putback 4.59
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.55
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.53
PTHrP overexpression in MCF7 cells 4.5
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 4.49
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 4.46
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.33
Differentiation enhances Zika virus infection in neuronal brain cells 4.32
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 4.22
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.2
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.15
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.14
Transcription elongation regulates genome 3D structure 4.12
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.12
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.1
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.1
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 4.0
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.95
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 3.94
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 3.93
The transcriptome and chromatin accessbility landscape of mammalian germline 3.86
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.86
Alagille_Nodder 3.85
RNA Seq of Alagille liver biopsies 3.85
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.83
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 3.73
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 3.72
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.72
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.71
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.71
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 3.62
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 3.62
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.61
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 3.58
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.56
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 3.53
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 3.45
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.43
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.4
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.39
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.36
The cohesin release factor WAPL restricts chromatin loop extension. 3.32
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.32
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.29
RNA-seq analysis of control and Myc-induced U2OS cells 3.26
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.25
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.24
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.2
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.2
Solid phase chemistry to covalently and reversibly capture thiolated RNA 3.2
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 3.18
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.16
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.16
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 3.16
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 3.11
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.11
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 3.1
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.07
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 3.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.02
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.02
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.96
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 2.95
Widespread regulated alternative splicing of single codons accelerates proteome evolution 2.91
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.88
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.84
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.83
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.83
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.83
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.78
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.77
Transcriptome analysis of peripheral blood monocytes 2.75
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.73
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.7
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.69
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.69
Transcriptomic profile of human embryonic renal corpuscles 2.6
MCF10A H-Ras RNA-Seq 2.59
Transcriptome of U251 cells overexpression complement component 7 2.54
Determining mRNA half-lives on a transcriptome-wide scale 2.54
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.53
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.52
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.48
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.48
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.48
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.47
Universal alternative splicing of noncoding exons 2.45
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.44
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.44
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.36
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.36
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.28
Identification of renal resident macrophages across species [C1] 2.27
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 2.26
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.25
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.25
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.22
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 2.18
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.17
MicroRNA-125a-5p overexpression in human macrophages 2.16
EGR1-controlled transcriptome of T HESCs 2.16
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.15
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.15
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.11
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.09
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.04
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.04
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 2.02
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.01
Gene expression profiling of leukemia cells following asparagine depletion 2.0
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.98
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 1.98
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.96
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.87
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.81
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.8
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.75
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.75
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.7
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.64
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.64
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.64
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.64
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.53
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.53
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.52
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.46
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.44
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.44
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.4
Iron response of HepG2 cells 1.39
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.37
Postnatal lipids drive hepatocyte maturation 1.35
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.34
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.3
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.3
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.28
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 1.24
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 1.24
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.24
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.24
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.17
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.15
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.15
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.12
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.12
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 1.09
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.07
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.04
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.04
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.96
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.95
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.94
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.93
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.92
The role of m6A/m-RNA methylation in stress response regulation 0.89
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.89
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.87
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.86
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.84
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.79
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.77
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.76
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.72
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.71
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.65
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.6
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.58
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.55
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.55
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.54
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.53
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.53
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.52
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.5
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.5
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.49
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.49
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.49
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.48
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.47
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.44
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.4
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.38
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 0.35
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.34
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.31
Comparative Analysis of Cas9 Activators Across Multiple Species 0.29
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.29
A code of mono-phosphorylation modulates the function of RB. 0.29
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.29
Modulation of nonsense-mediated decay by rapamycin 0.26
Ribosome profiling upon inhibition of eIF4A 0.21
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.2
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.17
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.14
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.14
RNA-seq of primary patient AML samples 0.14
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.13
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 0.12
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.11
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.11
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.1
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 0.09
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.05
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
RNA-Seq and expression data from human adipose tissue 0.01
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation